Inclusion criteria . | Exclusion criteria . |
---|---|
Thoracic aortic aneurysm >50 mm wide | <20 years old |
Aneurysm enlarged by ≥5 mm in <12 months | Pregnancy |
Saccular aneurysm >10 mm in the maximum transverse direction | Estimated life expectancy <12 months |
Failure to indicate their intention to participate | |
New York Heart Association Class IV | |
Myocardial infarction within previous 3 months | |
Cerebral vascular accident with previous 3 months | |
Connective tissue disease (e.g. Marfans and Ehlers-Danlos syndrome) | |
History of bleeding diathesis (including a DIC score > 6, caused by aneurysm, without palliative therapy), coagulopathy or refusal to get blood transfusions | |
Sensitivity or allergy to stainless steel, ePTFE, PVDF, contrast media or heparin | |
Unclear cerebellar arteries or Circle of Willis, requiring a stent-graft repair of the sub-clavian artery but without prior bilateral sub-clavian artery bypass | |
No planned blockage of the LSA, with a <10-mm proximal LZ from the LSA to the aneurysm | |
No planned blockage of the left carotid artery, with a <10-mm proximal LZ from the left carotid artery to the aneurysm | |
No planned blockage of the brachiocephalic trunk, with <10 mm proximal LZ from the brachiocephalic trunk to the aneurysm | |
Planned blockage of the celiac trunk, with an unclear connection between the SMA to the celiac trunk via the pancreaticoduodenal arcade | |
Planned blockage of the celiac trunk, with a <15-mm proximal LZ from the SMA to the aneurysm | |
No planned blockage of the celiac trunk, with a <15-mm proximal LZ from the celiac trunk to the aneurysm | |
Unfavourable access route with calcification, stenosis and tortuous iliac | |
Unfavourable LZ with calcification, mural haematoma and atheroma | |
Significant formation of atheroma in the access route, with risk of atherothrombosis | |
Thoracic aneurysm with a contained rupture | |
Aortic diameter of <18 or >43 mm in the proximal LZ | |
Active systemic infection |
Inclusion criteria . | Exclusion criteria . |
---|---|
Thoracic aortic aneurysm >50 mm wide | <20 years old |
Aneurysm enlarged by ≥5 mm in <12 months | Pregnancy |
Saccular aneurysm >10 mm in the maximum transverse direction | Estimated life expectancy <12 months |
Failure to indicate their intention to participate | |
New York Heart Association Class IV | |
Myocardial infarction within previous 3 months | |
Cerebral vascular accident with previous 3 months | |
Connective tissue disease (e.g. Marfans and Ehlers-Danlos syndrome) | |
History of bleeding diathesis (including a DIC score > 6, caused by aneurysm, without palliative therapy), coagulopathy or refusal to get blood transfusions | |
Sensitivity or allergy to stainless steel, ePTFE, PVDF, contrast media or heparin | |
Unclear cerebellar arteries or Circle of Willis, requiring a stent-graft repair of the sub-clavian artery but without prior bilateral sub-clavian artery bypass | |
No planned blockage of the LSA, with a <10-mm proximal LZ from the LSA to the aneurysm | |
No planned blockage of the left carotid artery, with a <10-mm proximal LZ from the left carotid artery to the aneurysm | |
No planned blockage of the brachiocephalic trunk, with <10 mm proximal LZ from the brachiocephalic trunk to the aneurysm | |
Planned blockage of the celiac trunk, with an unclear connection between the SMA to the celiac trunk via the pancreaticoduodenal arcade | |
Planned blockage of the celiac trunk, with a <15-mm proximal LZ from the SMA to the aneurysm | |
No planned blockage of the celiac trunk, with a <15-mm proximal LZ from the celiac trunk to the aneurysm | |
Unfavourable access route with calcification, stenosis and tortuous iliac | |
Unfavourable LZ with calcification, mural haematoma and atheroma | |
Significant formation of atheroma in the access route, with risk of atherothrombosis | |
Thoracic aneurysm with a contained rupture | |
Aortic diameter of <18 or >43 mm in the proximal LZ | |
Active systemic infection |
LZ: landing zone; SMA: superior mesenteric artery; DIC: disseminated intravascular coagulation; ePTFE: expanded polytetrafluoroethylene; PVDF: polyvinylidene fluoride.
Inclusion criteria . | Exclusion criteria . |
---|---|
Thoracic aortic aneurysm >50 mm wide | <20 years old |
Aneurysm enlarged by ≥5 mm in <12 months | Pregnancy |
Saccular aneurysm >10 mm in the maximum transverse direction | Estimated life expectancy <12 months |
Failure to indicate their intention to participate | |
New York Heart Association Class IV | |
Myocardial infarction within previous 3 months | |
Cerebral vascular accident with previous 3 months | |
Connective tissue disease (e.g. Marfans and Ehlers-Danlos syndrome) | |
History of bleeding diathesis (including a DIC score > 6, caused by aneurysm, without palliative therapy), coagulopathy or refusal to get blood transfusions | |
Sensitivity or allergy to stainless steel, ePTFE, PVDF, contrast media or heparin | |
Unclear cerebellar arteries or Circle of Willis, requiring a stent-graft repair of the sub-clavian artery but without prior bilateral sub-clavian artery bypass | |
No planned blockage of the LSA, with a <10-mm proximal LZ from the LSA to the aneurysm | |
No planned blockage of the left carotid artery, with a <10-mm proximal LZ from the left carotid artery to the aneurysm | |
No planned blockage of the brachiocephalic trunk, with <10 mm proximal LZ from the brachiocephalic trunk to the aneurysm | |
Planned blockage of the celiac trunk, with an unclear connection between the SMA to the celiac trunk via the pancreaticoduodenal arcade | |
Planned blockage of the celiac trunk, with a <15-mm proximal LZ from the SMA to the aneurysm | |
No planned blockage of the celiac trunk, with a <15-mm proximal LZ from the celiac trunk to the aneurysm | |
Unfavourable access route with calcification, stenosis and tortuous iliac | |
Unfavourable LZ with calcification, mural haematoma and atheroma | |
Significant formation of atheroma in the access route, with risk of atherothrombosis | |
Thoracic aneurysm with a contained rupture | |
Aortic diameter of <18 or >43 mm in the proximal LZ | |
Active systemic infection |
Inclusion criteria . | Exclusion criteria . |
---|---|
Thoracic aortic aneurysm >50 mm wide | <20 years old |
Aneurysm enlarged by ≥5 mm in <12 months | Pregnancy |
Saccular aneurysm >10 mm in the maximum transverse direction | Estimated life expectancy <12 months |
Failure to indicate their intention to participate | |
New York Heart Association Class IV | |
Myocardial infarction within previous 3 months | |
Cerebral vascular accident with previous 3 months | |
Connective tissue disease (e.g. Marfans and Ehlers-Danlos syndrome) | |
History of bleeding diathesis (including a DIC score > 6, caused by aneurysm, without palliative therapy), coagulopathy or refusal to get blood transfusions | |
Sensitivity or allergy to stainless steel, ePTFE, PVDF, contrast media or heparin | |
Unclear cerebellar arteries or Circle of Willis, requiring a stent-graft repair of the sub-clavian artery but without prior bilateral sub-clavian artery bypass | |
No planned blockage of the LSA, with a <10-mm proximal LZ from the LSA to the aneurysm | |
No planned blockage of the left carotid artery, with a <10-mm proximal LZ from the left carotid artery to the aneurysm | |
No planned blockage of the brachiocephalic trunk, with <10 mm proximal LZ from the brachiocephalic trunk to the aneurysm | |
Planned blockage of the celiac trunk, with an unclear connection between the SMA to the celiac trunk via the pancreaticoduodenal arcade | |
Planned blockage of the celiac trunk, with a <15-mm proximal LZ from the SMA to the aneurysm | |
No planned blockage of the celiac trunk, with a <15-mm proximal LZ from the celiac trunk to the aneurysm | |
Unfavourable access route with calcification, stenosis and tortuous iliac | |
Unfavourable LZ with calcification, mural haematoma and atheroma | |
Significant formation of atheroma in the access route, with risk of atherothrombosis | |
Thoracic aneurysm with a contained rupture | |
Aortic diameter of <18 or >43 mm in the proximal LZ | |
Active systemic infection |
LZ: landing zone; SMA: superior mesenteric artery; DIC: disseminated intravascular coagulation; ePTFE: expanded polytetrafluoroethylene; PVDF: polyvinylidene fluoride.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.